Zinoviev Maxim Vladimirovich (V. I. Vernadsky Crimean Federal University (Simferopol))
Umerova Olga Petrovna (V. I. Vernadsky Crimean Federal University (Simferopol))
Kalafatova Nazife Edemovna (V. I. Vernadsky Crimean Federal University (Simferopol))
Emirveli Sabrie Muratovna (V. I. Vernadsky Crimean Federal University (Simferopol))
Tevfikova Leila Zairovna (V. I. Vernadsky Crimean Federal University (Simferopol))
Arakelyan Emma Alikovna (V. I. Vernadsky Crimean Federal University (Simferopol))
| |
Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects millions of people around the world. Traditional treatments, mainly aimed at reducing the frequency of exacerbations and slowing the progression of the disease, are often limited in effectiveness and can have significant side effects. In this regard, the scientific community is actively looking for new approaches to MS therapy, striving to improve the quality of life of patients and offer longer-term treatment prospects.
Keywords:multiple sclerosis, monoclonal antibodies, alemtuzumab, natalizumab
|
|
| |
|
Read the full article …
|
Citation link:
Zinoviev M. V., Umerova O. P., Kalafatova N. E., Emirveli S. M., Tevfikova L. Z., Arakelyan E. A. NEW APPROACHES IN THE TREATMENT OF MULTIPLE SCLEROSIS: INNOVATIVE METHODS AND DEVELOPMENT PROSPECTS // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и Технические Науки. -2024. -№11/2. -С. 165-167 DOI 10.37882/2223-2966.2024.11-2.12 |
|
|
